Patents by Inventor Gabriel Billings

Gabriel Billings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Live attenuated cholera vaccine with probiotic properties
    Patent number: 11484585
    Abstract: Provided herein are genetically engineered Vibrio cholerae bacterial strains, compositions including the bacterial strains, and methods of using the same for the prevention of Vibrio cholerae infection in a subject.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: November 1, 2022
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Matthew K. Waldor, Troy Hubbard, Gabriel Billings
  • QUATERNARY AMMONIUM SALTS AS INHIBITORS OF TRIMETHYLAMINE PRODUCTION
    Publication number: 20220041641
    Abstract: Provided are compounds that can inhibit pathogenic, bacterial metabolite production and conjugates of the same. Also provided are pharmaceutical compositions comprising the same and methods of using the same.
    Type: Application
    Filed: December 6, 2019
    Publication date: February 10, 2022
    Inventors: Kathleen NUDEL, Jenny LIU, Timothy BRIGGS, Dinara Shashanka GUNASEKERA, Ana MARTINEZ-DEL CAMPO, Elijah BOGART, Steven TAYLOR, John PROUDFOOT, Cheri ROSS, Yohannes TEFFERA, Koji YASUDA, Devin Forest Reed DOUD, Gabriel BILLINGS, Spencer Cory PECK, Danny LAFRANCE, Kehinde AJAYI
  • LIVE ATTENUATED CHOLERA VACCINE WITH PROBIOTIC PROPERTIES
    Publication number: 20200268868
    Abstract: Provided herein are genetically engineered Vibrio cholerae bacterial strains, compositions including the bacterial strains, and methods of using the same for the prevention of Vibrio cholerae infection in a subject.
    Type: Application
    Filed: July 12, 2018
    Publication date: August 27, 2020
    Inventors: Matthew K. Waldor, Troy Hubbard, Gabriel Billings